Literature DB >> 15364101

Patterns of cytokine induction by gram-positive and gram-negative probiotic bacteria.

Martin L Cross1, Anja Ganner, Diaa Teilab, Linley M Fray.   

Abstract

Bacteria used in commercial probiotic preparations are most commonly gram-positive lactic acid-producing species, although there are also some probiotic products which utilise gram-negative coliform bacteria. Characterising how the innate immune system responds to these bacteria in vitro may give an indication as to the likely immunomodulatory events that can be triggered following probiotic administration in vivo. Here, an established gram-positive probiotic (Lactobacillus casei Shirota) was compared against a novel gram-negative probiotic strain (Escherichia coli Nissle 1917) for its ability to induce cytokine production in a cell type representative of the innate immune system; in addition, responses were contrasted against those induced by an enteropathogenic coliform, E. coli 2282. We investigated the ability of these three bacterial strains to modulate production of interleukins-10, -12 and -18; tumour necrosis factor-alpha; interferon-alpha; and transforming growth factor-beta, via a series of in vitro culture experiments involving the murine monocyte/macrophage cell line J774A.1. All bacteria induced marked secretion of IL-12 and TNFalpha by cells, while only coliforms induced production of IL-10; there was minimal or no induction of IL-18 or TGFbeta. Activation of cells with recombinant gamma-interferon promoted increased production of IL-12, but decreased production of IL-10, in response to the co-culture of coliform bacteria, indicating differential cytokine induction depending on the activation status of the target cell. In general, live bacteria stimulated higher levels of IL-10, IL-12 and TNFalpha secretion than heat-killed preparations, while only live coliforms induced IFNalpha. These findings are discussed in relation to the likely immunomodulatory effects of gram-positive and gram-negative bacteria on the innate immune system in vivo, with particular emphasis on the marked similarity in cytokine response patterns observed between probiotic versus pathogenic coliform bacteria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364101     DOI: 10.1016/j.femsim.2004.04.001

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  46 in total

1.  Selective effects of Lactobacillus casei Shirota on T cell activation, natural killer cell activity and cytokine production.

Authors:  H Dong; I Rowland; K M Tuohy; L V Thomas; P Yaqoob
Journal:  Clin Exp Immunol       Date:  2010-05-07       Impact factor: 4.330

2.  Immunomodulatory activity of two potential probiotic strains in LPS-stimulated HT-29 cells.

Authors:  Raj Kumar Duary; Virender Kumar Batish; Sunita Grover
Journal:  Genes Nutr       Date:  2014-03-30       Impact factor: 5.523

Review 3.  Probiotics manipulate host cytokine response and induce antimicrobial peptides.

Authors:  I Trebichavský; I Splíchal
Journal:  Folia Microbiol (Praha)       Date:  2006       Impact factor: 2.099

Review 4.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

5.  The immunomodulatory properties of probiotic microorganisms beyond their viability (ghost probiotics: proposal of paraprobiotic concept).

Authors:  Valentina Taverniti; Simone Guglielmetti
Journal:  Genes Nutr       Date:  2011-04-16       Impact factor: 5.523

Review 6.  Probiotics: properties, examples, and specific applications.

Authors:  Judith Behnsen; Elisa Deriu; Martina Sassone-Corsi; Manuela Raffatellu
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

Review 7.  Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update.

Authors:  Alessandro Di Cerbo; Federica Pezzuto; Lucia Palmieri; Valentina Rottigni; Tommaso Iannitti; Beniamino Palmieri
Journal:  Int Urol Nephrol       Date:  2013-04-13       Impact factor: 2.370

8.  Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice.

Authors:  Benoît Foligné; Joëlle Dewulf; Pascal Vandekerckove; Georges Pignède; Bruno Pot
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

9.  Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model.

Authors:  Sara Schumann; Carl Alpert; Wolfram Engst; Gunnar Loh; Michael Blaut
Journal:  Appl Environ Microbiol       Date:  2011-12-30       Impact factor: 4.792

10.  The K5 capsule of Escherichia coli strain Nissle 1917 is important in mediating interactions with intestinal epithelial cells and chemokine induction.

Authors:  Mohamed Hafez; Kelly Hayes; Marie Goldrick; Geoff Warhurst; Richard Grencis; Ian S Roberts
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.